Skip to content

Effect of remimazolam tosilate and propofol on circulation and sedation of colonoscopy

Effect of remimazolam tosilate and propofol on circulation and sedation of colonoscopy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062667
Enrollment
Unknown
Registered
2022-08-15
Start date
2022-08-20
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestion

Interventions

group P:introvenous propofol 2mg/kg
group R:introvenous remimazolam 0.2mg/kg

Sponsors

Zhuji People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Aged 18-64 years, gender unlimited, ASA I-II, BMI 18-30 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Known allergies to benzodiazepines or dairy products, has a history of bronchial asthma, myasthenia gravis patients, patients with schizophrenia and severe depression; 2. Pregnant and lactating women; 3. Patients with endoscopic check contraindicated; 4. Patients with difficult intubation have predictable, severe sleep apnea, obese patients, patients with severe bradycardia, patients with acute upper gastrointestinal bleeding; 5. Patients with preoperative history of hypertension, patients without history of hypertension but preoperation with SBP (systolic blood pressure) >= 160mmHg, DBP (diastolic blood pressure) >= 95mmHg, HR (heart rate) >= 110 beats/min or <= 50 beats/min.

Design outcomes

Primary

MeasureTime frame
feasibility of performing colonoscopy;the effect of anesthesia;

Secondary

MeasureTime frame
patients' body movement during colonoscopy;dose addition time points during colonoscopy;addition dosage;dose addition times;awaking time after colonoscopy;SpO2;blood pressure;

Countries

China

Contacts

Public ContactZhao Gang

Zhuji People's Hospital

zg991337@126.com+86 13735215515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026